US Stock MarketDetailed Quotes

Praxis Precision Medicines (PRAX)

Watchlist
  • 306.670
  • +8.930+3.00%
Trading Jan 16 11:35 ET
8.40BMarket Cap-23.64P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Praxis Precision Medicines (PRAX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
249.53%8.55M
1,349.13%7.46M
-35.47%302K
-54.29%357K
-36.90%431K
2.45M
515K
Operating revenue
--0
--0
--0
249.53%8.55M
1,349.13%7.46M
-35.47%302K
-54.29%357K
-36.90%431K
--2.45M
--515K
Cost of revenue
Gross profit
Operating expense
37.14%78.36M
101.00%76.07M
76.59%74.73M
62.02%208.72M
152.18%71.42M
119.89%57.14M
5.89%37.85M
9.14%42.32M
-40.08%128.82M
-31.68%28.32M
Selling and administrative expenses
-17.66%12.56M
23.39%13.06M
-9.20%13.92M
33.89%56.31M
52.33%15.13M
74.87%15.26M
4.52%10.59M
15.55%15.33M
-29.85%42.05M
-24.31%9.93M
-General and administrative expense
-17.66%12.56M
23.39%13.06M
-9.20%13.92M
33.89%56.31M
52.33%15.13M
74.87%15.26M
4.52%10.59M
15.55%15.33M
-29.85%42.05M
-24.31%9.93M
Research and development costs
57.10%65.8M
131.13%63.01M
125.34%60.81M
75.66%152.41M
206.11%56.29M
142.65%41.88M
6.43%27.26M
5.80%26.98M
-44.04%86.77M
-35.09%18.39M
Operating profit
-37.87%-78.36M
-102.91%-76.07M
-78.41%-74.73M
-58.39%-200.17M
-130.01%-63.96M
-122.74%-56.84M
-7.23%-37.49M
-9.96%-41.89M
41.22%-126.37M
32.92%-27.81M
Net non-operating interest income expense
Other net income (expense)
-10.15%4.43M
2.68%4.94M
132.83%5.43M
460.27%17.35M
468.64%5.28M
457.13%4.93M
642.44%4.81M
266.82%2.33M
223.51%3.1M
231.43%928K
Other non- operating income (expenses)
-10.15%4.43M
2.68%4.94M
132.83%5.43M
460.27%17.35M
468.64%5.28M
457.13%4.93M
642.44%4.81M
266.82%2.33M
223.51%3.1M
231.43%928K
Income before tax
-42.43%-73.93M
-117.67%-71.13M
-75.20%-69.3M
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
Income tax
Net income
-42.43%-73.93M
-117.67%-71.13M
-75.20%-69.3M
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
Net income continuous Operations
-42.43%-73.93M
-117.67%-71.13M
-75.20%-69.3M
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
Minority interest income
Net income attributable to the parent company
-42.43%-73.93M
-117.67%-71.13M
-75.20%-69.3M
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-42.43%-73.93M
-117.67%-71.13M
-75.20%-69.3M
-48.30%-182.82M
-118.32%-58.68M
-110.74%-51.91M
4.77%-32.68M
-5.60%-39.55M
42.40%-123.28M
34.72%-26.88M
Basic earnings per share
-22.18%-3.36
-90.23%-3.31
-15.85%-3.29
45.37%-10.21
-50.00%-2.94
-1.10%-2.75
76.42%-1.74
73.16%-2.84
73.17%-18.69
84.98%-1.96
Diluted earnings per share
-22.18%-3.36
-90.23%-3.31
-15.85%-3.29
45.37%-10.21
-50.00%-2.94
-1.10%-2.75
76.42%-1.74
73.16%-2.84
73.17%-18.69
84.98%-1.96
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 000249.53%8.55M1,349.13%7.46M-35.47%302K-54.29%357K-36.90%431K2.45M515K
Operating revenue --0--0--0249.53%8.55M1,349.13%7.46M-35.47%302K-54.29%357K-36.90%431K--2.45M--515K
Cost of revenue
Gross profit
Operating expense 37.14%78.36M101.00%76.07M76.59%74.73M62.02%208.72M152.18%71.42M119.89%57.14M5.89%37.85M9.14%42.32M-40.08%128.82M-31.68%28.32M
Selling and administrative expenses -17.66%12.56M23.39%13.06M-9.20%13.92M33.89%56.31M52.33%15.13M74.87%15.26M4.52%10.59M15.55%15.33M-29.85%42.05M-24.31%9.93M
-General and administrative expense -17.66%12.56M23.39%13.06M-9.20%13.92M33.89%56.31M52.33%15.13M74.87%15.26M4.52%10.59M15.55%15.33M-29.85%42.05M-24.31%9.93M
Research and development costs 57.10%65.8M131.13%63.01M125.34%60.81M75.66%152.41M206.11%56.29M142.65%41.88M6.43%27.26M5.80%26.98M-44.04%86.77M-35.09%18.39M
Operating profit -37.87%-78.36M-102.91%-76.07M-78.41%-74.73M-58.39%-200.17M-130.01%-63.96M-122.74%-56.84M-7.23%-37.49M-9.96%-41.89M41.22%-126.37M32.92%-27.81M
Net non-operating interest income expense
Other net income (expense) -10.15%4.43M2.68%4.94M132.83%5.43M460.27%17.35M468.64%5.28M457.13%4.93M642.44%4.81M266.82%2.33M223.51%3.1M231.43%928K
Other non- operating income (expenses) -10.15%4.43M2.68%4.94M132.83%5.43M460.27%17.35M468.64%5.28M457.13%4.93M642.44%4.81M266.82%2.33M223.51%3.1M231.43%928K
Income before tax -42.43%-73.93M-117.67%-71.13M-75.20%-69.3M-48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M
Income tax
Net income -42.43%-73.93M-117.67%-71.13M-75.20%-69.3M-48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M
Net income continuous Operations -42.43%-73.93M-117.67%-71.13M-75.20%-69.3M-48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M
Minority interest income
Net income attributable to the parent company -42.43%-73.93M-117.67%-71.13M-75.20%-69.3M-48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -42.43%-73.93M-117.67%-71.13M-75.20%-69.3M-48.30%-182.82M-118.32%-58.68M-110.74%-51.91M4.77%-32.68M-5.60%-39.55M42.40%-123.28M34.72%-26.88M
Basic earnings per share -22.18%-3.36-90.23%-3.31-15.85%-3.2945.37%-10.21-50.00%-2.94-1.10%-2.7576.42%-1.7473.16%-2.8473.17%-18.6984.98%-1.96
Diluted earnings per share -22.18%-3.36-90.23%-3.31-15.85%-3.2945.37%-10.21-50.00%-2.94-1.10%-2.7576.42%-1.7473.16%-2.8473.17%-18.6984.98%-1.96
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +7.12%
Sample Name
Sample Code
 +2.79%
Sample Name
Sample Code
 +2.47%
4
Broadcom
AVGO
+1.37%
5
Microsoft
MSFT
+0.99%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.40%
Sample Name
Sample Code
 +9.98%
Sample Name
Sample Code
 +8.92%
4
Kingsoft Cloud
KC
+6.72%
5
Taiwan Semiconductor
TSM
+6.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -